corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8240

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Hicks AR, Jackson MW, Barnard JF.
Pharmacoeconomic strategies for treating HIV patients in an indigent clinic
ASHP Midyear Clinical Meeting 1997 Dec; 32:


Abstract:

The cost of providing drug therapy to HIV patients is staggering. Most patients at our institution, who meet compliance guidelines, are on triple antiretroviral therapy at an average cost of $800/month. Many of our patients are also on prophylaxis therapy for MAC, PCP, and Candidiasis which can add an additional $250 or more per month to the cost of therapy. This report explains the methods used to provide prescription assistance to our HIV patients and how we were able to obtain over $84,000 of medications for 58 patients through pharmaceutical manufacturers’ assistance programs. Furthermore, by utilizing these patient assistance programs, we were able to justify the cost of a clinical pharmacist in the Retroviral Disease Clinic to provide these and other clinical services to this patient population.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.